CAMV
AMGN icon

Concord Asset Management (Virginia)’s Amgen AMGN Stock Holding History

Concord Asset Management (Virginia)’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.08M Sell
8,742
-370
-4% -$132K 0.52% 51
2025
Q4 		$2.98M Sell
9,112
-21
-0.2% -$6.66K 0.52% 48
2025
Q3 		$2.58M Sell
9,133
-334
-4% -$96.9K 0.47% 54
2025
Q2 		$2.64M Buy
9,467
+705
+8% +$200K 0.4% 62
2025
Q1 		$2.43M Buy
8,762
+526
+6% +$155K 0.54% 49
2024
Q4 		$2.15M Buy
8,236
+182
+2% +$54K 0.47% 55
2024
Q3 		$2.59M Buy
8,054
+786
+11% +$257K 0.59% 46
2024
Q2 		$2.27M Buy
7,268
+759
+12% +$223K 0.56% 46
2024
Q1 		$1.85M Buy
6,509
+771
+13% +$226K 0.49% 50
2023
Q4 		$1.65M Buy
5,738
+2,818
+97% +$768K 0.49% 46
2023
Q3 		$785K Buy
2,920
+738
+34% +$184K 0.26% 63
2023
Q2 		$485K Buy
2,182
+577
+36% +$134K 0.17% 72
2023
Q1 		$388K Buy
1,605
+734
+84% +$180K 0.16% 69
2022
Q4 		$229K Buy
+871
New +$233K 0.15% 55

Other funds holding AMGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Concord Asset Management (Virginia)'s AMGN Position: Q1 2026 in Review

Concord Asset Management (Virginia) reduced its Amgen (AMGN) stake by 4.1% in Q1 2026, selling an estimated $132K and leaving 8,742 shares worth $3.08M. The position accounts for 0.52% of the portfolio, ranked #51.

Concord Asset Management (Virginia) first reported a position in AMGN in Q4 2022 and has held it in 14 quarters since. 3,126 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Concord Asset Management (Virginia) held 8,742 shares of Amgen worth $3.08M as of Q1 2026.
  • Concord Asset Management (Virginia) sold 370 Amgen shares in Q1 2026, an estimated $132K.
  • Amgen made up 0.52% of Concord Asset Management (Virginia)'s portfolio in Q1 2026, its #51 holding.
  • Concord Asset Management (Virginia) first reported a position in Amgen in Q4 2022 and has held it in 14 quarters since.
  • 3,126 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Concord Asset Management (Virginia)'s 13F filing for Q1 2026, filed 1 May 2026.